Natglycan LLC

Tucker, GA

UEI
NMMMHXNPL8U5
CAGE
7KV47
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
1860 Montreal Rd, Tucker, GA 30084, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

About the company

Natglycan LLC is a for-profit limited liability company that provides glycomics products and services. Through federal grants from the National Institutes of Health, Natglycan develops techniques and platforms to study glycans and glycan binding proteins, which play important roles in biological processes.

Natglycan has received over $4.6 million in federal grant funding to support projects related to functional glycomics. This includes developing methods to isolate and purify natural glycans, as well as create glycan libraries and arrays to study protein-glycan interactions. Natglycan has partnered with the National Institute of General Medical Sciences and the National Institute of Dental and Craniofacial Research, utilizing grant funding to establish discovery platforms to elucidate novel glycans and glycan binding proteins involved in processes like microbial pathogenesis and oral innate immunity. Specific aims have included interrogating interactions between oral streptococcal adhesins and natural human salivary glycans, identifying glycans and glycan binding proteins related to early microbial colonization, and developing an array representing the diverse glycan structures found in human milk.

Quick answers

Is Natglycan LLC registered in SAM.gov?

Yes. Natglycan LLC's SAM.gov registration is active through July 8, 2027.

What is Natglycan LLC's most recent federal award?

Natglycan LLC's most recent federal grant award is A human salivary glycome discovery platform for interrogating glycan function in oral innate immunity (R43DE031990), from National Institute of Dental and Craniofacial Research (NIH), on September 1, 2022.

On GovTribe

See Natglycan LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors